CF
CF Industries
Materials · Fertilizers & Agricultural Chemicals · US
✓ ETHICAL PASS
STRONG MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$19.1B
Total market value of the company
12.17
Based on estimated future earnings — lower means cheaper
Rev Growth
+19.4%
Year-over-year revenue change
Profit Margin
23.7%
How much profit the company keeps from each dollar of revenue
27.3%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$122.58
+8% from current price — median analyst estimate
Recommendation
HOLD
Consensus view from 19 analysts covering this stock
About CF Industries
CF Industries Holdings, Inc., together with its subsidiaries, engages in the production of ammonia in North America, Europe, and internationally. It operates through Ammonia, Granular Urea, UAN, AN, and Other segments. The company offers ammonia products; nitrogen products, such as granular urea, urea ammonium nitrate solution, and ammonium nitrate; diesel exhaust fluid, urea liquor, and nitric acid products. It serves cooperatives, retailers, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Northbrook, Illinois.
https://www.cfindustries.com
Country: United States Employees: 2,900 Industry: Agricultural Inputs
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
25.8% PASS
Debt must be below 33% of total assets
Cash Ratio
0.2% PASS
Interest-bearing cash below 33% of assets
Receivables
17.2% PASS
Receivables below 49% of assets
Revenue Purity
1.1% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
$198.61
What our model estimates this business is worth per share
42.9%
Trading below fair value — margin of safety exists
Rating
OPPORTUNITY
Overall assessment combining ethics, valuation, and quality
99.1th
Ranks in the top 1% of our 13,571 screened universe
Trading at $125 against a fair value of $199, a 37% discount. Strong competitive moat. 24% profit margins. Passes all ethical screens. Ranks better than 99% of screened stocks.
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
MARKUP
Price trending up with increasing momentum
0.812
Good returns relative to risk taken
0.0715
Suggested allocation is meaningful — the edge justifies a position
0.895
Acceptable balance between returns and drawdown risk
Annual Return
26.1%
Historical annualised return based on price data
-29.2%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
10
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
0.42
Very low correlation to market moves
52W High
$141.96
20% below the year high
52W Low
$75.42
50% above the year low
Avg Volume
4,804,029
Average daily shares traded — higher means easier to buy and sell
1.9
Days it would take all short sellers to cover — higher means more crowded
Short % Float
6.0%
Moderate short interest
1.6%
Annual dividend as a percentage of the share price
$11.10
Earnings per share over the last 12 months
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
0.44
Conservative use of debt — low financial risk
3.54
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
2.92
Like current ratio but excludes inventory — stricter test
Gross Margin
39.1%
Revenue left after cost of goods — higher means pricing power
Operating Margin
33.6%
Profit from core operations before interest and tax
$1.1B
Positive — the business generates more cash than it spends
Revenue (TTM)
$7.4B
Total revenue over the last 12 months
Net Income
$1.8B
Profitable — the bottom line is positive
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date |
Insider |
Title |
Type |
Shares |
Value |
| 2026-04-28 |
WHITE CELSO L |
Director |
|
1,390 |
— |
| 2026-04-28 |
DEHAAS DEBORAH L. |
Director |
|
1,390 |
— |
| 2026-04-28 |
MADRAZO YRIS JESUS |
Director |
|
1,390 |
— |
| 2026-04-28 |
NOONAN ANNE P |
Director |
|
2,208 |
— |
| 2026-04-28 |
ELLERBUSCH SUSAN A. |
Director |
|
1,390 |
— |
| 2026-04-28 |
AHMED JAVED |
Director |
|
1,390 |
— |
| 2026-04-28 |
WAGLER THERESA E. |
Director |
|
1,390 |
— |
| 2026-04-28 |
TOELLE MICHAEL |
Director |
|
1,390 |
— |
| 2026-04-28 |
EAVES JOHN W |
Director |
|
1,390 |
— |
| 2026-04-28 |
ARZBAECHER ROBERT C |
Director |
|
1,390 |
— |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity
Congressional trading disclosures involving this instrument
| Date |
Politician |
Party |
Type |
Amount |
| 6 Apr2026 |
Josh Gottheimer |
Democrat |
buy |
1K–15K |
| 21 Apr2026 |
Susie Lee |
Democrat |
sell |
1K–15K |
| 15 Apr2026 |
Josh Gottheimer |
Democrat |
buy |
1K–15K |
| 14 Apr2026 |
Thomas Kean Jr |
Republican |
sell |
1K–15K |
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15